Back to search

Netherlands· NL-7e7d864a9f36

Pregabaline Mylan Pharma 25 mg, harde capsules

A medicinal product containing pregabaline, registered in Netherlands by Mylan S.A.S.

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPregabaline Mylan Pharma 25 mg, harde…ATC—REGISTER NO.NL-7e7d864a9f36PACKS LISTED1CHECKEDSeptember 29, 2026

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PREGABALINE
Manufacturer
Mylan S.A.S
Country
Netherlands (NL)
ATC code
—
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/15/998

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pregabaline in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pregabaline products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lynagex, Lynagex 165 Mg
  • Belgium · Lynagex, Pregabalin Ab
  • Bulgaria · Pregabin, Бриека
  • Cyprus · Epibal, Grabilen
  • Czechia · Kartesada, Naxalgan
  • Germany · Pregabador, Pregabahexal
  • Denmark · Galberin, Lyribastad
  • Estonia · Brieka, Bulgaplin
  • Spain · Aciryl, Apregia
  • Finland · Lyribastad, Pregabalin Grindeks
  • France · Lexenu, Lexenu 75 Mg
  • United Kingdom (Northern Ireland) · Alzain, Avellar
  • Greece · Algecia, Apregalin
  • Croatia · Pragiola, Pregabalin Belupo
  • Hungary · Kartesada, Naxalgan
  • Ireland · Pregabalin Basics, Pregabalin Brillpharma (Ireland)
  • Iceland · Brieka, Lyrica
  • Italy · Aclaton, Ecubalin
  • Liechtenstein · Lyrica, Pregabalin Accord
  • Lithuania · Brieka, Bulgaplin
  • Luxembourg · Pregabalin Micro Labs, Pregabaline Eg
  • Latvia · Brieka, Bulgaplin
  • Malta · Epibal, Pragiola
  • Norway · Lyrica, Pregabalin 1a Farma
  • Poland · Bulgaplin, Egzysta
  • Portugal · Kartesada, Lygabrin
  • Romania · Lynagex, Pragiola
  • Sweden · Brieka, Bulgaplin
  • Slovenia · Pragiola, Pregabalin Grindeks
  • Slovakia · Kartesada, Naxalgan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a847ab51-73b8-4d1d-bb8b-07056d135548
GET /v1/drugs/a847ab51-73b8-4d1d-bb8b-07056d135548?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pregabalin-mylan-pharma-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": null,
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116102",
  "excipients": [
    "AMMONIA (E 527)",
    "ERYTHROSINE (E 127)",
    "GELATINE (E 441)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAÏSZETMEEL",
    "NATRIUMLAURILSULFAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "PREGABALINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2015/06/25",
  "procedure_number": "EMEA/H/C/003962",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/998",
  "additional_monitoring": "N"
}

See everything about pregabaline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.